Oncology News

Physicians who demonstrate empathy in their interactions with individuals with breast cancer foster better psychological well-being and adjustment in this patient population, according to a study published in Patient Education and Counseling.

SAN ANTONIO — The combination of zanidatamab, palbociclib and fulvestrant yielded promising PFS results among adults with HER2-positive/hormone receptor-positive metastatic breast cancer, findings from a phase 2A study showed.

Women with benign breast disease diagnosed by percutaneous biopsies had an increased overall breast cancer risk compared with the general population, according to cohort study results published in JAMA Surgery.

Clinician-patient breast density conversations need to address worries, concerns and unanswered questions, especially for Hispanic and Asian women and those with low literacy, according to survey findings published in JAMA Network Open.

SAN ANTONIO — The addition of atezolizumab to chemotherapy, trastuzumab and pertuzumab did not significantly increase pathologic complete response rates among women with HER2-positive breast cancer.

SAN ANTONIO — Women aged 50 years or older who de-escalated to less-frequent mammography 3 years after curative surgery for early-stage breast cancer had similar outcomes to women who received annual mammography.

More than 20% of BRCA mutation carriers became pregnant within 10 years after receiving an early breast cancer diagnosis, and pregnancy did not affect disease-free survival, researchers reported in JAMA.

Among routinely screened women, annual vs. biennial screening was not a strong risk factor for advanced breast cancer and accounted for a small proportion of diagnoses, according to cohort study results published in JAMA Oncology.

Come the new year, a “mini” pill could have a massive impact in rheumatology care.

Women who regularly attended their mammogram screenings before a breast cancer diagnosis had up to a 72% reduced risk for death compared with those who attended none, according to a recent study.